A concealed cause of hypotension – case respor
Authors:
Karvunidis Thomas; Danihel Vojtěch; Chvojka Jiří; Ledvinová Lenka; Raděj Jaroslav; Novák Ivan; Matějovič Martin
Authors‘ workplace:
JIP, I. Interní klinika FN Plzeň a LF v Plzni Univerzity Karlovy v Praze
Published in:
Anest. intenziv. Med., 26, 2015, č. 1, s. 23-28
Category:
Intesive Care Medicine - Case Report
Overview
The case report presents a rare case of repeated paroxysms of significant hypotension with other clinical signs of systemic illness and discusses appropriate diagnostic methods and therapeutic management.
Keywords:
hypotension – mastocytosis – echocardiography – left ventricular outflow tract dynamic obstruction
Sources
1. Akin, C., Metcalfe, D. D. Systemic mastocytosis. Annu. Rev. Med., 2004, 55, p. 419–432.
2. Garcia-Montero, A. C., Jara-Acevedo, M., Teodosio, C. et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood, 2006, 108, p. 2366–2372.
3. Akin, C. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J. Mol. Diagn., 2006, 8, p. 412–419.
4. Fuller, S. J. New insights into the pathogenesis, diagnosis, and management of mastocytosis. Hematol. Oncol. Clin. North. Am., 2012, 26, p. 1143–1168.
5. Verstovsek, S. Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression. Eur. J. Haematol., 2013, 90, p. 89–98.
6. Sperr, W. R., Valent, P. Diagnosis, progression patterns and prognostification in mastocytosis. Expert. Rev. Hematol., 2012, 5, p. 261–274.
7. Pardanani, A. Systemic mastocytosis: disease overview, pathogenesis, and treatment. Hematol. Oncol. Clin. North Am., 2012, 26, p. 1117–1128.
8. Schwartz, L. B., Irani, A. M. Serum tryptase and the laboratory diagnosis of systemic mastocytosis. Hematol. Oncol. Clin. North Am., 2000, 14, p. 641–657.
9. Butterfield, J. H., Weiler, C. R. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production. Int. Arch. Allergy Immunol., 2008, 147, p. 338–343.
10. Akin, C., Valent, P., Metcalfe, D. D. Mast cell activation syndrome: Proposed diagnostic criteria. J. Allergy Clin. Immunol., 2010, 126, p. 1099–1104.
11. Valent, P., Akin, C., Arock, M. et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int. Arch. Allergy Immunol., 2012, 157, p. 215–225.
12. Chockalingam, A., Tejwani, L., Aggarwal, K. et al. Dynamic left venticular outflow tract obstruction in acute myocardial infarction with shock: cause, effect, and coincidence. Circulation, 2007, 116, p. 110–113.
13. Bybee, K. A., Prasad, A. Stress-related cardiomyopathy syndromes. Circulation, 2008, 118, p. 397–409.
14. El Mahmoud, R., Mansencal, N., Pilliere, R. et al. Prevalence and characteristics of left ventricular outflow tract obstruction in Tako-Tsubo syndrome. Am. Heart J., 2008, 156, p. 543–548.
15. Chockalingam, A., Xie, G. Y. Echocardiography in stress cardiomyopathy and acute LVOT obstruction. Int. J. Cardiovasc. Imaging, 2010, 26, p. 527–535.
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2015 Issue 1
Most read in this issue
- Perioperative hypotermia in elective therapeutical and diagnostic procedures
- A concealed cause of hypotension – case respor
- A man with painless jaundice, anaemia and intermittent chest pain – case report
- Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Societyand the European Society of Intensive Care Medicine